Our studys emphasis on direct cardiac and hepatic mechanisms, independent of significant weight loss, strengthens the rationale for exploring lower doses of GLP-1RAs in these diverse cardiovascular conditions to potentially maximize benefits while minimizing metabolic side effects
3.8 years), as was the duration of exposure to the trial regimen (2.4 years vs
All reagents were purchased from commercial suppliers and used accordingly
LncRNA H19 initiates microglial pyroptosis and neuronal death in retinal ischemia/reperfusion injury
After all, thousands of chemicals are out there, and were just beginning to understand how they work on the bodynot to mention how they work in conjunction with one another
These medications are rewriting the weight loss narrative by offering science-backed, sustainable solutions for those struggling with obesity or excess weight